dc.contributor.author | Weickert, Martin O. | |
dc.contributor.author | Reimann, Manja | |
dc.contributor.author | Otto, Bärbel | |
dc.contributor.author | Hall, Wendy L. | |
dc.contributor.author | Vafeiadou, Katerina | |
dc.contributor.author | Hallund, Jesper | |
dc.contributor.author | Ferrari, Marika | |
dc.contributor.author | Talbot, Duncan | |
dc.contributor.author | Branca, Francesco | |
dc.contributor.author | Bügel, Susanne | |
dc.contributor.author | Williams, Christine M | |
dc.contributor.author | Zunft, Hans-Joachim | |
dc.contributor.author | Koebnick, Corinna | |
dc.date.accessioned | 2013-10-14T13:30:28Z | |
dc.date.available | 2013-10-14T13:30:28Z | |
dc.date.issued | 2006 | |
dc.identifier.citation | Weickert , M O , Reimann , M , Otto , B , Hall , W L , Vafeiadou , K , Hallund , J , Ferrari , M , Talbot , D , Branca , F , Bügel , S , Williams , C M , Zunft , H-J & Koebnick , C 2006 , ' Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women ' , Journal of Negative Results in BioMedicine , vol. 5 , 11 . https://doi.org/10.1186/1477-5751-5-11 | |
dc.identifier.issn | 1477-5751 | |
dc.identifier.uri | http://hdl.handle.net/2299/11777 | |
dc.description | © 2006 Weickert et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited | |
dc.description.abstract | Soy isoflavones show structural and functional similarities to estradiol. Available data indicate that estradiol and estradiol-like components may interact with gut "satiety hormones" such as peptide YY (PYY) and ghrelin, and thus influence body weight. In a randomized, double-blind, placebo-controlled, cross-over trial with 34 healthy postmenopausal women (59 +/- 6 years, BMI: 24.7 +/- 2.8 kg/m2), isoflavone-enriched cereal bars (50 mg isoflavones/day; genistein to daidzein ratio 2:1) or non-isoflavone-enriched control bars were consumed for 8 weeks (wash-out period: 8-weeks). Seventeen of the subjects were classified as equol producers. Plasma concentrations of ghrelin and PYY, as well as energy intake and body weight were measured at baseline and after four and eight weeks of each intervention arm. | en |
dc.format.extent | 6 | |
dc.format.extent | 260488 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Negative Results in BioMedicine | |
dc.subject | Aged | |
dc.subject | Body Weight | |
dc.subject | Cross-Over Studies | |
dc.subject | Double-Blind Method | |
dc.subject | Fasting | |
dc.subject | Female | |
dc.subject | Ghrelin | |
dc.subject | Humans | |
dc.subject | Isoflavones | |
dc.subject | Middle Aged | |
dc.subject | Peptide Hormones | |
dc.subject | Peptide YY | |
dc.subject | Postmenopause | |
dc.subject | Soy Foods | |
dc.title | Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women | en |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Department of Human and Environmental Sciences | |
dc.contributor.institution | Health & Human Sciences Research Institute | |
dc.contributor.institution | Agriculture, Food and Veterinary Sciences | |
dc.contributor.institution | Food Policy, Nutrition and Diet | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1186/1477-5751-5-11 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |